Trials / Enrolling By Invitation
Enrolling By InvitationNCT05503927
A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy
Wegovy® (Semaglutide 2.4 mg) Database Study: A Population-based Cohort Study to Investigate Safety Outcomes of Exposure to Wegovy During Pregnancy
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,139 (estimated)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- Female
- Age
- 15 Years – 45 Years
- Healthy volunteers
- —
Summary
This is an observational, retrospective, cohort study using administrative insurance claims data. The aim of this non-interventional study (NIS) is to compare maternal, fetal and infant outcomes of women exposed to Wegovy during pregnancy to a reference population not exposed to Wegovy, so that participants and healthcare providers can make informed treatment decisions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | This is a non-interventional study, therefore no intervention is used. |
Timeline
- Start date
- 2023-01-02
- Primary completion
- 2027-08-15
- Completion
- 2027-08-15
- First posted
- 2022-08-17
- Last updated
- 2026-01-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05503927. Inclusion in this directory is not an endorsement.